4.6 Article

Plasmodium falciparum-infected erythrocytes adhere both in the intervillous pace and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 164, Issue 6, Pages 2013-2025

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9440(10)63761-3

Keywords

-

Categories

Funding

  1. FIC NIH HHS [5D42TW01264, D43 TW001264] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI045086, R21 AI045086, AI43888, AI45086, U01 AI043888] Funding Source: Medline

Ask authors/readers for more resources

In pregnant women infected with Plasmodium falciparum, the parasite-infected red blood cells (IRBCs) sequester in the placenta through chondroitin 4-sulfate (C4S)-mediated adherence. The pattern of IRBC adherence in P. falciparum-infected placenta has been controversial. Moreover, the identity of the chondroitin sulfate proteoglycan (CSPG) receptor, that mediates IRBC adherence, and its location in the placenta have not been established. This study, using immunohistochemical techniques, clearly shows, for the first time, that the low-sulfated CSPGs of the placenta are localized predominantly in the intervillous space. Ex vivo IRBC adherence analyses demonstrate that the IRBCs are adhered to the CSPG receptors in the placenta in a C4S-dependent manner. This IRBC binding pattern was similar to that observed in P. falciparum-infected placentas. These data and the results of dual-fluorescence staining of the endogenous RBCs and syncytiotrophoblasts, and co-localization of CSPG and HIBC adherence unequivocally establish that the low-sulfated CSPGs are the major natural receptors for IRBC adherence in the placenta. Further, it was found that IRBCs adhere mainly in the intervillous space and also at significant levels to the syncytiotrophoblasts. Finally, the ex vivo IRBC adherence method described herein provides a reliable procedure for future studies for the assessment of the efficacy of C4S inhibitors and adhesion inhibitory antibodies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available